In conclusion, our signature can provide clinicians with prognostic predictions and help guide the treatment of patients with DLBCL.
No takes yet. Share an insight, caveat, or question.
Sheng et al. (2023) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: